Breast implants are artificial devices (prostheses), which are surgically inserted into the breast, for the augmentation of the breast, which is called as mammoplasty. Breast implants are made up of silicone shells that are filled with either silicone gel or saline (sterile salt water).
Breast implantation is performed for multiple reasons such as women with mastectomy (breast removal due to cancer), women whose breast size has reduced after pregnancy, weight loss or aging, women with asymmetrical breasts, and women who want to improve their self-esteem and body image.
In the breast implants category, silicone breast implants are highly preferred options among women seeking breast augmentation procedure, as they appear more firm and appealing in comparison to saline breast implants. Breast implants comes in different sizes and shapes ranging from low profile to high profile implants.
The global breast implants market is estimated to be valued at US$ 1,299.9 million in 2021 and is expected to exhibit a CAGR of 4.2% over the forecast period (2021-2028)
Figure 1. Global Breast Implants Market Share (US$ Mn), By Region, 2021
The increasing patients of breast cancer is expected to drive growth of the global breast implants market over the forecast period.
For instance, in 2020, according to the World Health Organisation (WHO) there were 2.3 million women diagnosed with breast cancer and 685, 000 deaths globally.
|Base Year:||2020||Market Size in 2021:||US$ 1,299.9 Mn|
|Historical Data for:||2017 to 2020||Forecast Period:||2021 to 2028|
|Forecast Period 2021 to 2028 CAGR:||4.2%||2028 Value Projection:||US$ 1,739.0 Mn|
Abbvie, Inc, CEREPLAS, Establishment Labs S.A., GC Aesthetics, GROUPE SEBBIN SAS, Guangzhou Wanhe Plastic Materials Co., Ltd., HansBiomed Co., Ltd., Ideal Implant Inc, Laboratoires Anios, Mentor Worldwide LLC, Polytech Health & Aesthetics GmbH, Shanghai Kangning Medical Device Co., Ltd, Sientra, Inc., and Silimed.
|Restraints & Challenges:||
Figure 2. Global Breast Implants Market Value (%), By Product Type, 2021
The increasing research and development activities for the faster recovery and less post-operative pain is expected to drive the market growth over the forecast period.
For instance, in April 2021, Establishment Labs has completed enrolment of one hundred patient in Motiva MIA IRB study, where the study demonstrates a significant advancement in breast aesthetics, relative to traditional augmentation surgery, MIA offers a shorter procedure time without the need for general anaesthesia, reduced recovery time, and lower post-operative pain.
The increasing product launches and approvals are expected to drive the market growth over the forecast period.
For instance, in December 2021, GC Aesthetics, Inc (GCA), a privately held medical technology company providing aesthetics solutions for global healthcare market, launched PERLE, a highly innovative line of smooth breast implant that features a proprietary surface technology.
Global Breast Implants Market – Impact of Coronavirus (Covid-19) Pandemic
Coronavirus (COVID-19) outbreak was first reported on December 31, 2019, in Wuhan, China. The World Health Organization declared COVID-19, as pandemic on March 11, 2020. According to the Coronavirus (COVID-19) Weekly Epidemiological Update by the World Health Organization, over 281,808,270 cases and 5,411,759 deaths due to coronavirus disease (COVID-19) were reported till December 29, 2021, across the globe.
The COVID-19 pandemic and lockdown in various countries across the globe has negatively impacted the financial status of businesses across all sectors. The COVID-19 pandemic has impacted the entire supply chain of the healthcare industry mainly due to strict lockdown in several regions.
For instance, according to the America Society of Plastic Surgeons, number of breast augmentation procedures performed in 2019 were 287,085 and the number reduced to 193,073 in 2020.
Global Breast Implants Market – Restraint
The risk associated with breast implants such as breast pain, changes in nipple, additional surgeries, breast implants associated anaplastic large cell lymphoma (BIA-ALCL), connective tissue disease, issue in breast feeding, and capsular contracture factors are expected to hinder the growth of global breast implants market over the forecast period. For instance, in 2020, according to American Society of Plastic Surgeons 36,367 breast implants removal (Augmentation patients only) were performed in the U.S.
Major players operating in the global breast implant market include Abbvie, Inc, CEREPLAS, Establishment Labs S.A., GC Aesthetics, GROUPE SEBBIN SAS, Guangzhou Wanhe Plastic Materials Co., Ltd., HansBiomed Co., Ltd, Ideal Implant Inc, Laboratoires Anios, Mentor Worldwide LLC, Polytech Health & Aesthetics GmbH, Shanghai Kangning Medical Device Co., Ltd, Sientra, Inc, and Silimed.
Breast implants are medical devices implanted under the breast tissue or chest muscle to increase breast size (augmentation) or to replace breast tissue that has been removed due to cancer or that has failed to develop properly due to severe breast abnormality (reconstruction). They are also used in revision surgeries to correct or improve the result of an original surgery. There are two types of breast implants approved in the U.S., which includes saline filled and silicone gel filled, both the types have a silicone outer shell that vary in size, shell thickness, shell surface texture, and shape.
Increasing awareness of breast reconstruction procedure has led to higher number of women opting for mastectomy procedure. Moreover, raising awareness of women towards breast augmentation procedures for beauty enhancement has resulted in higher breast implant procedures.
According to American Society of Plastic Surgeons, 193,073 breast augmentation surgeries were performed in U.S
The increasing prevalence of breast cancer, rising research and development activities for the development of novel breast implants, and increasing adoption of inorganic growth strategies such as mergers, acquisitions, partnerships, and collaborations by key players operating in the market are the major factors that are expected to drive growth of the global breast implants market over the forecast period.
For instance, according to breast cancer organization, in 2021, an estimated 281,550 new cases of invasive breast cancer were expected to be diagnosed in women in the U.S, along with 49,290 new cases of non-invasive breast cancer.
Key features of the study:
“*” marked represents similar segmentation in other categories in the respective section.